11-beta-hydroxyandrosterone has been researched along with Adenoma--Acidophil* in 1 studies
1 other study(ies) available for 11-beta-hydroxyandrosterone and Adenoma--Acidophil
Article | Year |
---|---|
The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly.
The urinary excretion of the androgen metabolites aetiocholanolone (E) and androsterone (A) as well as DHEA, 11-hydroxy-androsterone and the cortisol metabolites 11-oxo-aetiocholanolone and 11-hydroxyaetiocholanolone in normoprolactinaemic and hyperprolactinaemic male and female acromegalics was studied and compared with that of appropriate control groups. In addition several plasma hormones were also measured. The growth hormone level in the patient group varied from 10-550 mU/l. The excretion of both 11-hydroxy-androsterone and DHEA was normal. The excretion of androsterone had decreased, while aetiocholanolone and cortisol metabolite excretion had increased. The ratio between aetiocholanolone and androsterone (E/A) excretion was significantly increased in all patient groups, but no correlation was found between the growth hormone level and the E/A ratio. Treatment with bromocriptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged. After selective transsphenoidal removal of the pituitary adenoma the E/A ratio decreased significantly. The increased E/A ratio in untreated patients could not be attributed to eventual changes in plasma levels of cortisol, thyroxine, prolactin, testosterone or oestrogens. We therefore suggest that growth hormone is involved in androgen metabolism in acromegaly. Topics: Acromegaly; Adenoma, Acidophil; Androgens; Androsterone; Bromocriptine; Dehydroepiandrosterone; Etiocholanolone; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms | 1984 |